Lexaria’s Human Oral Nicotine Study Begins Dosing

December 20, 2022

Consumer Packaged Goods

Lexaria’s Technology Lowers Blood Glucose More Effectively than Rybelsus-Branded GLP-1 drug Semaglutide Alone in Human Pilot Study

November 28, 2023
Lexaria’s Technology Improves the Oral Performance of the Rybelsus-Branded GLP-1 drug Semaglutide in Human Pilot Study

November 27, 2023
Blue Star Foods Provides Shareholder Update

November 27, 2023
Bit Origin Ltd Announces New Financing and Provides Business Plan Update

November 22, 2023